122 related articles for article (PubMed ID: 6594318)
1. Evaluation of prednisolone and vincristine with and without L-asparaginase in acute lymphatic leukemia of childhood.
Choudhry VP; Marwaha RK; Goyal DP; Sarya AK
Indian J Pediatr; 1983; 50(407):619-22. PubMed ID: 6594318
[No Abstract] [Full Text] [Related]
2. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
[No Abstract] [Full Text] [Related]
3. [Consolidating chemotherapy in the treatment program of acute lymphoblastic leukemia in children].
Maiakova SA; Makhonova LA
Vestn Akad Med Nauk SSSR; 1986; (5):15-7. PubMed ID: 3487897
[No Abstract] [Full Text] [Related]
4. Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
van der Does-van den Berg A; van Wering ER; de Koning J; Rammeloo JA; Solbu G; Suciu S; van Zanen GE
Haematol Blood Transfus; 1987; 30():444-7. PubMed ID: 3305211
[No Abstract] [Full Text] [Related]
5. [Cerebellar infarction following remission induction therapy in acute lymphoblastic leukemia].
Aoki Y; Shibuya A; Ninomiya H; Nakazawa M; Nakamura H; Kageoka T; Nagasawa T; Yoda Y; Abe T
Rinsho Ketsueki; 1987 Apr; 28(4):624-8. PubMed ID: 3476768
[No Abstract] [Full Text] [Related]
6. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
Freeman AI
Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
[No Abstract] [Full Text] [Related]
7. Therapy of acute leukemia with drug combinations which include asparaginase.
Leventhal BG; Henderson ES
Cancer; 1971 Oct; 28(4):825-9. PubMed ID: 5286445
[No Abstract] [Full Text] [Related]
8. [Remission induction with vincristine and prednisolone alone in adult acute lymphocytic leukemia].
Saito K; Kajitani H; Okuyama A; Osato M; Hara M; Watanabe K; Dobashi Y; Yamazaki T; Hamaguchi H; Sakamaki H
Rinsho Ketsueki; 1984 Sep; 25(9):1388-93. PubMed ID: 6596449
[No Abstract] [Full Text] [Related]
9. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
[No Abstract] [Full Text] [Related]
10. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
Chessells JM; Cornbleet M
Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of reinductions in a modern protocol for the treatment of childhood acute lymphoblastic leukaemias. Analysis of the D-74 protocol (author's transl)].
Ortega JJ; Javier G
Sangre (Barc); 1981; 26(1):47-57. PubMed ID: 6942519
[No Abstract] [Full Text] [Related]
12. [Analysis of advances in the treatment of lymphoblastic leukemia].
Korczowski R; Jakieła T
Pediatr Pol; 1985 Jan; 60(1):15-9. PubMed ID: 3862055
[No Abstract] [Full Text] [Related]
13. [Results of treatment of children with acute lymphatic leukemia (ALL) according to the ALL V protocol of the Netherlands Working Group on Leukemia in Children].
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; Rammeloo JA; de Koning J; van Zanen GE
Tijdschr Kindergeneeskd; 1988 Apr; 56(2):61-6. PubMed ID: 3287685
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Amato KR; Sallan SE; Lipton JM
Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
[TBL] [Abstract][Full Text] [Related]
15. [Acute lymphoblastic leukemia in children. Long survivals obtained with protocols C2-72 and D-74 (1972-1977)].
Ortega JJ; Javier G; Montagut JM; Torán N
An Esp Pediatr; 1986 Feb; 24(2):87-97. PubMed ID: 3516041
[TBL] [Abstract][Full Text] [Related]
16. Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.
Den Boer ML; Harms DO; Pieters R; Kazemier KM; Gobel U; Körholz D; Graubner U; Haas RJ; Jorch N; Spaar HJ; Kaspers GJ; Kamps WA; Van der Does-Van den Berg A; Van Wering ER; Veerman AJ; Janka-Schaub GE
J Clin Oncol; 2003 Sep; 21(17):3262-8. PubMed ID: 12947061
[TBL] [Abstract][Full Text] [Related]
17. [Use of high doses of methotrexate in the program treatment of children with lymphoblastic leukemia].
Maiakova SA; Balakirev SA; Gavrilova IE; Drozdova TS; Makhonova LA
Gematol Transfuziol; 1985 Jul; 30(7):12-5. PubMed ID: 3863771
[No Abstract] [Full Text] [Related]
18. [Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
Kawai S; Fujimoto T; Hiyoshi Y; Nibu K; Ito M; Kadoya S; Shingaki Y
Rinsho Ketsueki; 1984 Jun; 25(6):819-26. PubMed ID: 6384569
[No Abstract] [Full Text] [Related]
19. [Treatment of children with acute lymphoblastic leukemia].
Pinkel' D
Gematol Transfuziol; 1991 Jan; 36(1):12-6. PubMed ID: 2065938
[No Abstract] [Full Text] [Related]
20. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]